79?ANZDATA,1999~2004, FU6.4yrs(mean)?高转运者(142APD,486CAPD)?APD组年龄更轻,白种人更多,糖尿病更少,在大中心治疗的比例更少;腹膜转运类型和CAPD组无差异CAPDAPDCAPDAPD生存率技术生存率techniquesurvivalGroupPatientsurvivalTechniquesurvivalUnivariate HR(95%CI)Multivariate HR(95%CI)Univariate HR(95%CI)Multivariate HR(95%CI)High0.57(0.35-0.94)0.56(0.35-0.87)0.93(0.67–1.28)0.88(0.64–1.21)High-A0.98(0.72-1.34)1.08(0.81-1.45)1.16(0.95–1.40)1.17(0.95–1.44)Low-A0.70(0.46-1.07)0.98(0.66-1.45)0.99(0.75–1.33)1.02(0.77–1.35)Low2.21(1.24-3.93)2.19(1.02-4.70)1.35(0.79–2.28)1.24(0.67–2.29)Nephrol Dial Trans-plant.2010;25:1973-1979进一步的病例对照分析显示:在年龄,糖尿病和种族匹配后,高R转es运ults患o者fin接ten受tion-to-t治rea疗t C仍ox然pr降op低ort了ion总al体ha死zar亡ds风m险odelanalysesof the relative haAzaPrDd of APD versus CAPD for patient surv(HivaRl a0n.d60,95% CI0.36–0.96)
全文预览
